HomeSZLS • TSE
add
StageZero Life Sciences Ltd
Previous close
$0.040
Year range
$0.040 - $0.055
Market cap
4.92M CAD
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 499.66K | -32.98% |
Operating expense | 242.93K | -70.37% |
Net income | -399.28K | 51.42% |
Net profit margin | -79.91 | 27.52% |
Earnings per share | — | — |
EBITDA | -337.00K | 53.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.03K | -37.61% |
Total assets | 580.75K | 14.23% |
Total liabilities | 11.71M | 22.16% |
Total equity | -11.13M | — |
Shares outstanding | 123.53M | — |
Price to book | -0.44 | — |
Return on assets | -151.19% | — |
Return on capital | 9.97% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -399.28K | 51.42% |
Cash from operations | 10.26K | -78.55% |
Cash from investing | — | — |
Cash from financing | -15.95K | 81.87% |
Net change in cash | -5.69K | 85.82% |
Free cash flow | 60.43K | -82.33% |
About
Founded
1997
Headquarters
Website
Employees
40
